{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:04:26Z","timestamp":1782281066611,"version":"3.54.5"},"posted":{"date-parts":[[2025,7,19]]},"group-title":"Cancer Biology","reference-count":91,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Pancreatic neuroendocrine tumors (PNET) are rare malignancies of the endocrine pancreas with diverse clinical outcomes. While some PNETs are indolent, others are aggressive and metastasize quickly. However, clinically-relevant molecular stratification for PNET to predict outcomes and guide therapeutic decision-making is limited. Thus, there is an urgent need to understand the molecular heterogeneity of PNETs to refine prognostication and discover novel therapeutic vulnerabilities. We performed single-nucleus RNA sequencing on resected primary and metastatic PNETs (\n                  <jats:italic>n<\/jats:italic>\n                  = 20), including two PNETs with neoadjuvant treatment. We inferred gene expression programs (GEPs) of malignant and non-malignant cells and investigated associations with clinical outcomes. Next, we inferred interactions in the tumor microenvironment (TME) and performed transwell assays for functional validation. Finally, we explored genomic and transcriptomic evolution in a unique case study of an untreated primary PNET with two asynchronous hepatic metastases. A malignant GEP enriched for neural\/synaptic signaling genes was associated with worse overall survival, broad chromosomal loss of heterozygosity, and alternative lengthening of telomeres. Another malignant GEP enriched for VEGF signaling increased throughout metastatic progression in our case study. We found that macrophage-derived glutamate drives polarization towards an immunosuppressive phenotype and activates the MAPK\/ERK pathway in malignant cells to increase migratory capacity. This study provides a detailed single-nucleus transcriptomic classification of malignant, stromal, and immune cell types and states in PNETs, their interactions in the TME, and associations with clinical outcomes. The refined molecular taxonomy of PNET may guide the development of more efficacious biomarkers and therapeutic strategies.\n                <\/jats:p>","DOI":"10.1101\/2025.07.15.664730","type":"posted-content","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:50:10Z","timestamp":1752972610000},"source":"Crossref","is-referenced-by-count":0,"title":["Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-8548","authenticated-orcid":false,"given":"Jeanna M.","family":"Arbesfeld-Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong T.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy A.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Muratani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zack","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Dries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fernandez-del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Heaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Lisa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"6","key":"2025072302150897000_2025.07.15.664730v1.1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.9738\/INTSURG-D-14-00204.1","article-title":"Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies","volume":"100","year":"2015","journal-title":"Int Surg"},{"key":"2025072302150897000_2025.07.15.664730v1.2","unstructured":"SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2023 Apr 19. [updated: 2023 Jun 8; cited 2023 Aug 23]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries."},{"issue":"3","key":"2025072302150897000_2025.07.15.664730v1.3","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/ERC-18-0420","article-title":"Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors","volume":"26","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2025072302150897000_2025.07.15.664730v1.4","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.3390\/cancers12113170","article-title":"Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic","volume":"12","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"2025072302150897000_2025.07.15.664730v1.5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-023-03299-6","article-title":"Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges","volume":"80","year":"2023","journal-title":"Endocrine"},{"key":"2025072302150897000_2025.07.15.664730v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nature21063"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.7","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41467-021-24812-3","article-title":"The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"2025072302150897000_2025.07.15.664730v1.8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0068"},{"key":"2025072302150897000_2025.07.15.664730v1.9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41525-018-0058-3","article-title":"Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer","volume":"3","year":"2018","journal-title":"NPJ Genomic Med"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.10","first-page":"1","article-title":"Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression","volume":"3","year":"2020","journal-title":"Commun Biol"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s42003-020-01469-0","article-title":"DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association","volume":"4","year":"2021","journal-title":"Commun Biol"},{"key":"2025072302150897000_2025.07.15.664730v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109817"},{"issue":"8","key":"2025072302150897000_2025.07.15.664730v1.13","doi-asserted-by":"crossref","first-page":"110544","DOI":"10.1016\/j.isci.2024.110544","article-title":"Proteogenomic characterization of pancreatic neuroendocrine tumors uncovers hypoxia and immune signatures in clinically aggressive subtypes","volume":"27","year":"2024","journal-title":"iScience"},{"key":"2025072302150897000_2025.07.15.664730v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0493-4"},{"key":"2025072302150897000_2025.07.15.664730v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06498-2"},{"issue":"6","key":"2025072302150897000_2025.07.15.664730v1.16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/PAS.0000000000001860","article-title":"Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors","volume":"46","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2025072302150897000_2025.07.15.664730v1.17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1401"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12885-021-08045-7","article-title":"CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor","volume":"21","year":"2021","journal-title":"BMC Cancer"},{"key":"2025072302150897000_2025.07.15.664730v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321016"},{"key":"2025072302150897000_2025.07.15.664730v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.337"},{"key":"2025072302150897000_2025.07.15.664730v1.21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add9668"},{"key":"2025072302150897000_2025.07.15.664730v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01134-8"},{"key":"2025072302150897000_2025.07.15.664730v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0844-1"},{"issue":"14","key":"2025072302150897000_2025.07.15.664730v1.24","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.7150\/ijbs.61717","article-title":"Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor","volume":"17","year":"2021","journal-title":"Int J Biol Sci"},{"key":"2025072302150897000_2025.07.15.664730v1.25","doi-asserted-by":"crossref","unstructured":"Ye Z , Zhou Y , Hu Y , Li Q , Xu Z , Lou X , et al. Single-cell sequencing reveals the heterogeneity of pancreatic neuroendocrine tumors under genomic instability and histological grading. iScience [Internet]. 2024 Sep 20 [cited 2025 May 1];27(9). Available from: https:\/\/www.cell.com\/iscience\/abstract\/S2589-0042(24)02061-3","DOI":"10.1016\/j.isci.2024.110836"},{"key":"2025072302150897000_2025.07.15.664730v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2016.09.002"},{"key":"2025072302150897000_2025.07.15.664730v1.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.010"},{"key":"2025072302150897000_2025.07.15.664730v1.28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128"},{"key":"2025072302150897000_2025.07.15.664730v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4463"},{"issue":"13","key":"2025072302150897000_2025.07.15.664730v1.30","first-page":"2491","article-title":"The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1+ pancreatic progenitor cells","volume":"134","year":"2007","journal-title":"Dev Camb Engl"},{"issue":"9","key":"2025072302150897000_2025.07.15.664730v1.31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12032-022-01715-x","article-title":"E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2","volume":"39","year":"2022","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"2025072302150897000_2025.07.15.664730v1.32","doi-asserted-by":"crossref","unstructured":"Zhang X , He X , Li Y , Xu Y , Chen W , Liu X , et al. MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis. Front Mol Biosci [Internet]. 2021 [cited 2024 Mar 1];8. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.702206","DOI":"10.3389\/fmolb.2021.702206"},{"key":"2025072302150897000_2025.07.15.664730v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00288-6"},{"key":"2025072302150897000_2025.07.15.664730v1.34","doi-asserted-by":"publisher","DOI":"10.7150\/thno.34973"},{"key":"2025072302150897000_2025.07.15.664730v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.08.027"},{"key":"2025072302150897000_2025.07.15.664730v1.36","doi-asserted-by":"publisher","DOI":"10.7150\/thno.55074"},{"key":"2025072302150897000_2025.07.15.664730v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)01452-2"},{"key":"2025072302150897000_2025.07.15.664730v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.03.022"},{"key":"2025072302150897000_2025.07.15.664730v1.39","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-017-0394-x"},{"key":"2025072302150897000_2025.07.15.664730v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113184"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.41","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/s41598-017-02761-6","article-title":"Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"2025072302150897000_2025.07.15.664730v1.42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1147"},{"issue":"3","key":"2025072302150897000_2025.07.15.664730v1.43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/SLA.0000000000003022","article-title":"Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases","volume":"271","year":"2020","journal-title":"Ann Surg"},{"key":"2025072302150897000_2025.07.15.664730v1.44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1207313"},{"key":"2025072302150897000_2025.07.15.664730v1.45","doi-asserted-by":"crossref","unstructured":"Tilsed CM , Fisher SA , Nowak AK , Lake RA , Lesterhuis WJ. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol [Internet]. 2022 Jul 29 [cited 2025 Jul 7];12. Available from: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2022.960317\/full","DOI":"10.3389\/fonc.2022.960317"},{"key":"2025072302150897000_2025.07.15.664730v1.46","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16075"},{"key":"2025072302150897000_2025.07.15.664730v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34395-2"},{"key":"2025072302150897000_2025.07.15.664730v1.48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162024"},{"key":"2025072302150897000_2025.07.15.664730v1.49","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0644"},{"key":"2025072302150897000_2025.07.15.664730v1.50","doi-asserted-by":"publisher","DOI":"10.1002\/path.6011"},{"key":"2025072302150897000_2025.07.15.664730v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39953-w"},{"key":"2025072302150897000_2025.07.15.664730v1.52","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0710"},{"key":"2025072302150897000_2025.07.15.664730v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.01.004"},{"key":"2025072302150897000_2025.07.15.664730v1.54","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22554"},{"key":"2025072302150897000_2025.07.15.664730v1.55","unstructured":"Chan JA , Geyer S , Zemla T , Knopp MV , Behr S , Pulsipher S , et al. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med [Internet]. [cited 2024 Sep 27];0(0). Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2403991"},{"key":"2025072302150897000_2025.07.15.664730v1.56","doi-asserted-by":"crossref","unstructured":"Yin Z , Wang L . Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy. Ann Med. 55(1):1058\u201369.","DOI":"10.1080\/07853890.2023.2180155"},{"key":"2025072302150897000_2025.07.15.664730v1.57","doi-asserted-by":"crossref","first-page":"929950","DOI":"10.3389\/fonc.2022.929950","article-title":"Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution","volume":"12","year":"2022","journal-title":"Front Oncol"},{"key":"2025072302150897000_2025.07.15.664730v1.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.008"},{"key":"2025072302150897000_2025.07.15.664730v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.010"},{"key":"2025072302150897000_2025.07.15.664730v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.07.030"},{"key":"2025072302150897000_2025.07.15.664730v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9"},{"key":"2025072302150897000_2025.07.15.664730v1.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-020-00415-7"},{"key":"2025072302150897000_2025.07.15.664730v1.63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.299081"},{"key":"2025072302150897000_2025.07.15.664730v1.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.08.012"},{"key":"2025072302150897000_2025.07.15.664730v1.65","doi-asserted-by":"crossref","unstructured":"Viola A , Munari F , S\u00e1nchez-Rodr\u00edguez R , Scolaro T , Castegna A. The Metabolic Signature of Macrophage Responses. Front Immunol [Internet]. 2019 [cited 2024 Feb 29];10. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2019.01462","DOI":"10.3389\/fimmu.2019.01462"},{"key":"2025072302150897000_2025.07.15.664730v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.05.045"},{"key":"2025072302150897000_2025.07.15.664730v1.67","doi-asserted-by":"publisher","DOI":"10.1101\/gad.342205"},{"key":"2025072302150897000_2025.07.15.664730v1.68","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2593"},{"issue":"11","key":"2025072302150897000_2025.07.15.664730v1.69","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s42255-023-00912-w","article-title":"PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy","volume":"5","year":"2023","journal-title":"Nat Metab"},{"key":"2025072302150897000_2025.07.15.664730v1.70","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2859"},{"key":"2025072302150897000_2025.07.15.664730v1.71","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1576-6"},{"key":"2025072302150897000_2025.07.15.664730v1.72","unstructured":"Peinado P , Stazi M , Ballabio C , Margineanu MB , Li Z , Col\u00f3n CI , et al. Intrinsic electrical activity drives small-cell lung cancer progression. Nature [Internet]. 2025 Feb 12 [cited 2025 Feb 25]; Available from: https:\/\/www.nature.com\/articles\/s41586-024-08575-7"},{"key":"2025072302150897000_2025.07.15.664730v1.73","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170221"},{"key":"2025072302150897000_2025.07.15.664730v1.74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003825"},{"issue":"19","key":"2025072302150897000_2025.07.15.664730v1.75","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.3390\/ijms20194949","article-title":"Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms","volume":"20","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025072302150897000_2025.07.15.664730v1.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.09.005"},{"key":"2025072302150897000_2025.07.15.664730v1.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.06.059"},{"key":"2025072302150897000_2025.07.15.664730v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.051"},{"key":"2025072302150897000_2025.07.15.664730v1.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.02.011"},{"key":"2025072302150897000_2025.07.15.664730v1.80","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322595"},{"key":"2025072302150897000_2025.07.15.664730v1.81","doi-asserted-by":"publisher","DOI":"10.1002\/0471142956.cy1240s73"},{"key":"2025072302150897000_2025.07.15.664730v1.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.06.018"},{"key":"2025072302150897000_2025.07.15.664730v1.83","unstructured":"Tickle T , Tirosh I , Brown M , Haas B. InferCNV of the Trinity CTAT Project. [Internet]. Cambridge, MA, USA: Klarman Cell Observatory, Broad Institute of MIT and Harvard; [cited 2023 Nov 12]. Available from: https:\/\/github.com\/broadinstitute\/infercnv"},{"key":"2025072302150897000_2025.07.15.664730v1.84","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43803"},{"key":"2025072302150897000_2025.07.15.664730v1.85","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2488"},{"key":"2025072302150897000_2025.07.15.664730v1.86","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90004-5"},{"key":"2025072302150897000_2025.07.15.664730v1.87","first-page":"1488","article-title":"Isolation of Mouse Peritoneal Cavity Cells","volume":"35","year":"2010","journal-title":"J Vis Exp JoVE"},{"key":"2025072302150897000_2025.07.15.664730v1.88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5"},{"key":"2025072302150897000_2025.07.15.664730v1.89","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2012-100918"},{"issue":"1","key":"2025072302150897000_2025.07.15.664730v1.90","first-page":"11.10.1","article-title":"From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline","volume":"43","year":"2013","journal-title":"Curr Protoc Bioinforma"},{"key":"2025072302150897000_2025.07.15.664730v1.91","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw520"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.07.15.664730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:13:38Z","timestamp":1782278018000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.07.15.664730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1101\/2025.07.15.664730","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1158\/1078-0432.CCR-25-2565","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,7,19]]},"subtype":"preprint"}}